参考文献/References:
[1]张娜娜,张振巍,石磊.女贞子抗肿瘤活性成分提取工艺考察[J].中国药师,2015,18(2):215-219. [2]谭文广,刘伟,鲁菲菲,等.女贞子中三萜化合物的提取与含量测定[J].食品科学,2006,27(11):260-262. [3]杨阳,易骏,马利,等.多指标正交试验优化女贞子中环烯醚萜苷的提取工艺[J].中国药房,2016,27(28):3970-3973. [4]徐小花,杨念云,钱士辉,等.女贞子黄酮类化合物的研究[J].中药材,2007,30(5):538-540. [5]张立海,宋友华,孙春华,等.反相高效液相色谱法测定女贞子中红景天苷的含量[J].中国药学杂志,2001,36(11):42-43. [6]Lin SY,Dan X,Du XX,et al.Protective Effects of Salidroside against Carbon Tetrachloride (CCl4)-Induced Liver Injury by Initiating Mitochondria to Resist Oxidative Stress in Mice[J]. Int J Mol Sci,2019,20(13):3187. [7]Feng J,Zhang Q,Mo W,et al.Salidroside pretreatment attenuates apoptosis and autophagy during hepatic ischemia–reperfusion injury by inhibiting the mitogen-activated protein kinase pathway in mice[J].Drug Des Devel Ther,2017(11):1989-2006. [8]Cai L,Li Y,Zhang Q,et al.Salidroside protects rat liver against ischemiareperfusion injury by regulating the GSK-3β/Nrf-2-dependent antioxidant response and mitochondrial permeability transition[J].Eur J Pharmacol,2017(806):32-42. [9]Lonardo A,Ballestri S,Marchesini G,et al.Nonalcoholic fatty liver disease:A precursor of the metabolic syndrome[J].Dig Liver Dis,2015,47(3):181-190. [10]Asrih M,Jornayvaz FR.Metabolic syndrome and nonalcoholic fatty liver disease:Is insulin resistance the link[J].Mol Cell Endocrinol,2015(418):55-65. [11]Castro GS,Cardoso JF,Vannucchi H,et al.Fructose and NAFLD:metabolic implications and models of induction in rats[J].Acta Cir Bras,2011(26 Suppl 2):45-50. [12]Yang ZR,Wang HF,Zuo TC,et al.Salidroside alleviates oxidative stress in the liver with non- alcoholic steatohepatitis in rats[J].BMC Pharmacol Toxicol,2016,17(1):16. [13]Zheng T,Yang X,Li W,et al.Salidroside Attenuates High-Fat Diet-Induced Nonalcoholic Fatty Liver Disease via AMPK-Dependent TXNIP/NLRP3 Pathway[J].Oxid Med Cell Longev,2018(2018):1-17. [14]Feng J,Chen K,Xia Y,et al.Salidroside ameliorates autophagy and activation of hepatic stellate cells in mice via NF-kB and TGF-β1/Smad3 pathways[J].Drug Des Devel Ther,2018(12):1837-1853. [15]吕红梅,张庆江.红景天苷对人肝癌HepG-2细胞MMP-1的表达及粘附能力的影响[J].中医药学报,2015,43(4):65-66. [16]Lu L,Liu S,Dong Q,et al.Salidroside suppresses the metastasis of hepatocellular carcinoma cells by inhibiting the activation of the Notch1 signaling pathway[J].Mol Med Rep,2019,19(6):4964-4972. [17]Wan XL,Lu YF,Xu SF,et al.Oeanolic acid protects against the hepatotoxicity of D-galactosame plus endotoxin in mice[J].Biomed Pharmacother,2017(93):1040-1046. [18]Wang W,Wu L,Li J,et al.Alleviation of Hepatic Ischemia Reperfusion Injury by Oleanolic Acid Pretreating via Reducing HMGB1 Release and Inhibiting Apoptosis and Autophagy[J].Mediators Inflamm,2019(2019):1-10. [19]Hao BB,Pan XX,Fan Y,et al.Oleanolic acid attenuates liver ischemia reperfusion injury by HO-1/Sesn2 signaling pathway[J].Hepatobiliary Pancreat Dis Int,2016,15(5):519-524. [20]Valic Z,Tappy L, Lê KA,et al.Metabolic Effects of Fructose and the Worldwide Increase in Obesity[J].Journal of Applied Physiology,2001,90(1):23-28,46. [21]Postic C,Girard J.Contribution of de novo fatty acid synthesis to hepatic steatosis and insulin resistance:lessons from genetically engineered mice[J].J Clin Invest,2008,118(3):829-838. [22]Liu C,Li Y,Zuo G,et al.Oleanolic Acid Diminishes Liquid Fructose-Induced Fatty Liver in Rats: Role of Modulation of Hepatic Sterol Regulatory Element-Binding Protein-1c-Mediated Expression of Genes Responsible for De Novo Fatty Acid Synthesis[J].Evid Based Complement Alternat Med,2013(2013):1-11. [23]Zhou RJ,Ye H,Wang F,et al.Apigenin inhibits d -galactosamine/LPS-induced liver injury through upregulation of hepatic Nrf-2 and PPARγ expressions in mice[J].Biochem Biophys Res Commun,2017,493(1):625-630. [24]Tsaroucha AK,Tsiaousidou A,Ouzounidis N,et al.Intraperitoneal administration of apigenin in liver ischemiareperfusion injury protective effects[J].Saudi J Gastroenterol,2016,22(6):415. [25]Lv Y,Gao X,Luo Y,et al.Apigenin ameliorates HFD-induced NAFLD through regulation of the XO/NLRP3 pathways[J].J Nutr Biochem,2019(71):110-121. [26]Hicks DF,Goossens N,Blas-García A,et al.Transcriptome-based repurposing of apigenin as a potential anti-fibrotic agent targeting hepatic stellate cells[J].Sci Rep,2017,7(1):42563. [27]庄让笑,潘旭旺,方红英,等.芹菜素纳米乳抗大鼠肝纤维化作用及对MMP-1,TIMP-1的影响[J].中国临床药理学与治疗学,2016,21(10):1122-1125. [28]Yang J,Pi C,Wang G.Inhibition of PI3K/Akt/mTOR pathway by apigenin induces apoptosis and autophagy in hepatocellular carcinoma cells[J].Biomedicine&Pharmacotherapy,2018(103):699-707. [29]胡冬梅.特女贞苷对四氯化碳致小鼠急性肝损伤的保护作用及其机制研究[D].西北大学,2017.